UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of ~~October~~November, 2017

Commission File Number: 001-15152

SYNGENTA AG

(Translation of registrant’s name into English)

Schwarzwaldallee 215

4058 Basel

Switzerland

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

Form 20-F

Form 40-F

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):

Yes

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):

Yes

Re:

SYNGENTA AG

Disclosure: “~~APPROVAL~~Syngenta OFto ~~DELISTING~~acquire OFNidera ~~SYNGENTA SHARES~~Seeds”

Herewith we furnish a press release related to Syngenta AG. The full text of the press release is the following:

# # #

Syngenta International AG Media Office CH-4002 Basel Switzerland Tel: +41 61 323 2323 Fax: +41 61 323 2424 www.syngenta.com Media contacts: ~~Sydne~~Andrew ~~Saccone~~McConville Switzerland +41 61 323 ~~2323~~0618 Paul Minehart USA +1 202 737 8913 media.relations@syngenta.com Analyst/Investor contacts: Andrew McConville Switzerland +41 61 323 0618 ~~USA +1 202 737 6521~~

~~Switzerland~~Basel, ~~Basel~~Switzerland, ~~October~~November 276, 2017

~~APPROVAL~~Syngenta to OFacquire ~~DELISTING~~Nidera OFSeeds ~~SYNGENTA SHARES~~

OnSyngenta 8and ~~March~~COFCO ~~2016,~~International ~~CNAC~~Ltd ~~Saturn (NL) B.V.,~~announced ~~Amsterdam,~~today ~~The~~that ~~Netherlands,~~Syngenta ahas ~~subsidiary~~entered ofinto ~~China~~a ~~National~~binding ~~Chemical~~agreement ~~Corporation~~to ~~(ChemChina),~~acquire ~~published~~Nidera ~~the~~Seeds ~~offer~~which ~~prospectus~~is ~~on the~~currently ~~public~~owned ~~tender~~by ~~offer~~COFCO ~~for~~International. Completion ~~all~~of ~~publicly~~the ~~held~~transaction ~~registered~~is ~~shares~~subject ofto ~~Syngenta~~clearance AGby at the ~~offer~~relevant ~~price~~merger-control ~~of USD 465 per registered share~~authorities. On 10Financial ~~May~~terms ~~2017,~~of ~~ChemChina announced that~~ the ~~public~~transaction are ~~tender~~not ~~offer was successful~~disclosed.

On 2 October 2017, Syngenta AG applied for the delisting of the Syngenta shares from SIX Swiss Exchange. On 26 October 2017, the request was approved by SIX Exchange Regulation.

The last trading day for the Syngenta shares and the effective date of the delisting will be determined after the final judgment in the cancellation proceedings regarding the remaining publicly held registered shares of Syngenta will be available. The cancellation proceedings were initiated by CNAC Saturn (NL) B.V. in July 2017.

About Syngenta

Syngenta is a leading agriculture company helping to improve global food security by enabling millions of farmers to make better use of available resources. Through world class science and innovative crop solutions, our 28,000 people in over 90 countries are working to transform how crops are grown. We are committed to rescuing land from degradation, enhancing biodiversity and revitalizing rural communities. To learn more visit www.syngenta.com and www.goodgrowthplan.com. Follow us on Twitter® at www.twitter.com/Syngenta.

Cautionary statement regarding forward-looking statements

Some of the statements contained in this press release are forward-looking statements. These statements are based on current expectations, assumptions, estimates and projections, and involve known and unknown risks, uncertainties and other factors that may cause results, levels of activity, performance or achievements to be materially different from any forward-looking statements. These statements are generally identified by words or phrases such as "believe", "anticipate", "expect", "intend", "plan", "will", "may", "should", "estimate", "predict", "potential", "continue" or the negative of such terms or other similar expressions. If underlying assumptions prove inaccurate or unknown risks or uncertainties materialize, actual results and the timing of events may differ materially from the results and/or timing discussed in the forward-looking statements, and you should not place undue reliance on these statements. Syngenta disclaims any intent or obligation to update any forward-looking statements as a result of developments occurring after the period covered by this press release or otherwise.

Syngenta – ~~October~~November 276, 2017 / Page 1 of 1

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
		SYNGENTA AG
Date:	~~October~~November 276, 2017	By:	/s/ ~~Tobias~~Brigitte ~~Meili~~Benz
			Name:	~~Dr.~~Brigitte ~~Tobias Meili~~Benz
			Title:	Head Shareholder Services & Group Administration
		By:	/s/ Tobias Meili
			Name:	Tobias Meili
			Title:	Head Corporate Legal Affairs
		By:	/s/ Markus Widmer
			Name:	Markus Widmer
			Title:	Corporate Legal Counsel

Filing Compare · SYNGENTA AG